How is early neonatal sepsis typically approached in terms of empiric therapy?

• A. Ampicillin plus gentamicin; or ampicillin plus gentamicin plus a third-generation cephalosporin.
• B. Oral antibiotics only.
• C. Wait for culture results before starting antibiotics.
• D. Vancomycin monotherapy.

Answer: (A)

Early neonatal sepsis requires immediate empiric therapy with IV antibiotics that cover the most common birth-associated pathogens, particularly group B Streptococcus and gram-negative bacteria such as E. coli. The standard initial approach pairs ampicillin with gentamicin because ampicillin provides coverage for GBS and Listeria, while gentamicin adds broad gram-negative activity. This combination gives rapid, broad-spectrum coverage while culture results are still pending. In cases with higher risk for meningitis or if the infant isn’t improving, adding a third-generation cephalosporin expands CNS-penetrant and gram-negative coverage, addressing pathogens that may not be fully covered by the two-drug combination alone.

Oral antibiotics are inappropriate here due to poor and unreliable absorption in newborns and the need for reliable therapeutic levels, and waiting for culture results before starting antibiotics risks rapid deterioration. Vancomycin as monotherapy would miss several common gram-negative pathogens and isn’t enough for early-onset sepsis without additional agents.